Aldeyra Therapeutics, Inc.
ALDX
$2.76
$0.103.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.77% | 1.96% | 27.26% | 50.69% | 39.47% |
| Total Depreciation and Amortization | -5.02% | -4.26% | -3.61% | -2.47% | 1.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.36% | -49.43% | -72.68% | -69.83% | -28.93% |
| Change in Net Operating Assets | 586.70% | 241.52% | 164.98% | -27.01% | 125.00% |
| Cash from Operations | -42.48% | 27.07% | 34.08% | 42.01% | 46.46% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -249.72% | -176.06% | -163.95% | -152.30% | 200.21% |
| Cash from Investing | -249.72% | -176.06% | -163.95% | -152.30% | 200.15% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 71.94% | -- | -- | -- | -- |
| Issuance of Common Stock | 27.22% | -75.17% | -78.83% | -78.32% | -74.98% |
| Repurchase of Common Stock | -- | 100.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 86.51% | -362.00% | -204.40% | -204.42% | -204.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5,430.94% | -612.21% | -363.00% | -1,122.05% | 98.13% |